Skip to main content
  • Policy
    Get Involved
    Watch Best of BIO
    Advocacy Toolkit
    BIOAction
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    Agriculture & Environment
    Food and Farm Innovation
    Sustainable Fuels
    Biobased Manufacturing
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Join Today
    Member Directory
    Have a Voice
    Membership Eligibility
    Benefits By Sector
    member health
    Human Health
    member startups
    Startups
    member ag&evnt
    Agriculture & Environment
    member non R&D
    Non-R&D Companies
    Member Savings
    BBS-Programs-vwr
    VWR, Part of Avantor
    75% off Lab Supplies
    BIO Business Solutions
    Join Today
  • News & Insights
    Latest blogs on BIOtechNOW
    Watch Best of BIO
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    Good Day BIO
    I AM BIO Podcast
    All News & Insights

    Sign up for the Good Day BIO Newsletter >

  • BIOEquality
    1. Promote

    Health equality in access to medicines and ensuring diversity in clinical trials.

    2. Invest

    In the current and next generation of black scientists and entrepreneurs.

    3. Expand

    Opportunities for women, Black and other minority populations in the growing Bio-economy.

    The Right Mix Matters

    Providing tools to accelerate gender, racial, ethnic and LGBTQ representation on biotech company boards, in C-suites and in functional leadership positions.

  • Events
    Event Portfolio
    Business Development
    Health
    Agriculture & Environment
    International
    Members Only
    All Events
    BIO Digital 2021

    June 10-18

    New extended dates for the world’s largest biotech partnering event

    Subscribe for Updates
    Evt Bif MegaMenu
    BIO Investor Forum Digital

    October 19-20, 2021
    Watch the Best of BIO Sessions

    BIO Partnering @ JPM
    BIO Patient & Health Advocacy Digital Summit

    October 27-28, 2021

    Evt CEO MegaMenu
    BIO CEO & Investor Digital Conference

    Watch the Best Sessions Now >

    BIO Online Learning

    BIO now offers on-demand online classes that can be taken anywhere, anytime and at your own pace. BIO Member and group discounts available!

  • About
    About Us
    Learn about our mission, vision, values and priorities
    Programs & Initiatives
    Find out about BIO's programs & initiatives
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
    Diversity & Inclusion

    Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.

  • How Do I
    How Do I?

    Connect with BIO to save money, meet partners and expand your influence by promoting your company and joining our advocacy efforts. Join to get started today!

    Shape Policy
    Save Money
    Meet Partners
    Promote
    Get Started
    Join Today
  • Search
Logo
Logo
Home
Search
  • Human Health
  • Agriculture & Environment
  • Business & Bio Industry
  • Policy & Regulatory
  • International Issues
  • Network & Partnering
  • Events
Logo
Logo
Search
Explore the Blog
  • Human Health
  • Agriculture & Environment
  • Business & Bio Industry
  • Policy & Regulatory
  • International Issues
  • Network & Partnering
  • Events
682 Results Found

Woman speaking to pharmacist
Here’s What You Need to Know as Capitol Hill Talks Prescription Drug Costs
Drug prices will be in the spotlight this week as committees in both the House and Senate are set to hold hearings on the cost of prescription drugs. Since this is the first time the new Congress will take a close look at this important issue, here are four facts we encourage policymakers to keep…

Photo of Senator Birch Bayh
Happy 91st Birthday Senator Bayh!
At its best, government enables citizens to flourish socially and economically. Above and beyond the basic services we all expect, responsible governments empower citizens to provide for themselves in a rapidly evolving world. Through Senator Birch Bayh’s long career of public service, he led a…

Despite Administration’s “Sky-High Rhetoric,” Importing Foreign Price Controls Will Harm Innovation and Patient Access
Despite Administration’s “Sky-High Rhetoric,” Importing Foreign Price Controls Will Harm Innovation and Patient Access
In October of 2018, the Trump Administration outlined a proposal that would import foreign price controls for medicines covered under Medicare Part B. Despite warnings from BIO and dozens of other industry experts and patient advocates, the administration continues to defend its flawed plan and…

The Right Way to Address Prescription Drug Costs
Writing for STAT News, BIO’s President and CEO Jim Greenwood teamed up with Bay City Capital’s David Beier to outline for policymakers the best approach for tackling the affordability of prescription drugs. “As policy professionals from different sides of the aisle, we believe there is a right way…

BIO Comments on Objectives for U.S. Japan Trade Agreement
BIO supports the U.S. Trade Representative’s (USTR) negotiations with the Government of Japan as an opportunity to grow U.S. exports and create U.S. jobs. We would strongly urge the U.S. government to build on the recent U.S.-Mexico-Canada agreement and that the agreement comprehensively addresses…

The Administration’s Orwellian Defense of Importing Foreign Price Controls
The Trump administration is out with a new blog post defending its plan to adopt foreign price controls for medicines covered under Medicare Part B. The blog was written in the wake of growing backlash from free-market thought leaders who are challenging the administration’s draconian proposal. …

Greenwood Talks Innovation, Drug Pricing, and the Midterm Elections on ForbesBooks Radio
During the Forbes Healthcare Summit, BIO CEO Jim Greenwood joined Gregg Stebben, host of ForbesBooks Radio, for a discussion about innovation taking place in the biopharma industry, the cost and value of prescription medicines and how the recent midterm elections may impact the drug pricing debate…

Think the Drug-Pricing debate addresses Patient Costs? Think again.
Writing for The Hill, BIO President and CEO Jim Greenwood tackled the drug pricing debate in Washington and touched on President Trump’s proposals for lowering drug prices. On the Administration’s recent International Pricing Index (IPI), which would move from a market-based payment formula for…

Another Year, Another Misleading Insurance Company Report
Once again, Blue Cross Blue Shield is out with a report attempting to stoke fear and confusion about prescription drug costs. And once again (because we’ve chronicled it before) what the major insurance company has to say is contradicted by its own pharmacy benefits manager. These drug cost…

Patient Advocates Sounding the Alarm Over Fail First
The Centers for Medicare & Medicaid Services (CMS) has reversed a long-standing policy allowing Medicare Advantage plans to impose “step therapy” requirements for physician-administered drugs – also known as Medicare Part B. More accurately described as “fail first,” this dangerous policy will…

Pagination

  • « « First
  • ‹ ‹‹
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • › ››
  • » Last »
Explore BIO
Policy
Events
Industry Insights
About
Join Now
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO Digital
BIO CEO & Investor Conference
BIO Investor Forum Digital
BIO IMPACT Digital
BIO Online Learning
BIO DOUBLE HELIX SPONSORS
Eli Lilly and Company
Amgen
Bristol Myers Squibb
Genentech Logo
Johnson & Johnson Logo
Merck
MSD
BIO HELIX SPONSORS
Pfizer Inc logo
Sanofi Logo
AbbVie Logo
1201 Maryland Avenue SW, Suite 900, Washington, DC, 20024 ・ 202-962-9200
© BIO 2021 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO